Trending Now
Small Cap Psychedelic Play Vying for Future Leadership in Addiction Treatment...
The addiction treatment space has been pummeled along with everything else in the growth side of the stock market so far in...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Where is ADMA Biologics Inc ($ADMA) headed next ?
In a recent close of the trading day, ADMA Biologics, Inc. (ADMA) showcased a notable rise, closing at $11.00, which marked an...
MAKE IT MODERN
LATEST REVIEWS
ABVC Biopharma Inc (NASDAQ: ABVC) Recently Issued an Update on PDC-1412
ABVC Biopharma Inc (NASDAQ: ABVC) recently issued an update of its PDC-1421 clinical study to its shareholders. The company announced that some of its...
MAKE IT MODERN
PERFORMANCE TRAINING
Gilead Sciences Inc. (NASDAQ:GILD) Announce $21 Billion Acquisition Of Cancer Drug Maker Immunomedics Inc....
Gilead Sciences Inc. (NASDAQ:GILD) has continued to boost its cancer portfolio with the latest announcement of the acquisition of Immunomedics Inc. (NASDAQ:IMMU)
Gilead enhancing oncology...
Markets snap back in normal fashion
Markets snapped back in normal fashion. Tech (QQQ) leads the way, up 1.5%, while most everything else is up about 1%. Bonds...
AC Immune SA (NASDAQ:ACIU) Reports Encouraging Results On the Study Of Its AD Vaccine
AC Immune SA (NASDAQ:ACIU) has released encouraging interim results from the on-going Phase 1b/2a clinical trial studying its first-in-class anti-phospho-Tau vaccine candidate ACY-35.030 in...
Genmab’s (NASDAQ:GMAB) Licensing Partner, Jansen Biotech Submits sBLA For DARZALEX FASPRO™ In Light-Chain Amyloidosis
Genmab A/S (NASDAQ:GMAB) has announced that Jansen Biotech Inc., its licensing partners, has submitted a supplemental Biologics Licence Application to the FDA for approval...
Genelux Corporation (GNLX) Stock Plummets After Pricing Public Offering
Genelux Corporation (NASDAQ: GNLX), a biopharmaceutical company dedicated to developing oncolytic immunotherapies, recently faced a dramatic decline in its stock price. Following...
MAKE IT MODERN
